The lawsuit alleges three manufacturers coordinated with three pharmacy benefit managers in a scheme to inflate insulin ...

Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...

HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...

Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing them of driving up insulin cost.

A high wind warning by the National Weather Service was issued for much of Washington state through Wednesday morning, including Hoquiam, Quinault, Humptulips, Westport, Tokeland, Raymond, Amanda Park ...